Fluo Labs: The Future of Allergy Relief (212)

Episode 12 May 14, 2022 00:25:00
Fluo Labs: The Future of Allergy Relief (212)
Innovation4Alpha
Fluo Labs: The Future of Allergy Relief (212)

May 14 2022 | 00:25:00

/

Show Notes

Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever) symptoms. They are inventing a whole new way for sufferers of seasonal allergies to get symptom relief, and ultimately improve their quality of life. The Fluo device is designed to use light therapy to reduce inflammation and temporarily alleviate allergy symptoms as a completely drug-free alternative to common allergy medications.

Other Episodes

Episode 5

February 09, 2022 00:43:54
Episode Cover

Jaffar Raza, MD - Opportunities, Cost Management and Technology (205)

Jaffar Raza, MD is a board certified Interventional Cardiologist affiliated with Lenox Hill, Hackensack and Holy name hospitals. He completed his residency in Internal...

Listen

Episode 14

May 21, 2022 00:18:54
Episode Cover

ScriptChain: Applying Artificial Intelligence to Chronic Heart Related Issues (214)

ScriptChain is a digital health platform that sits on top of EHR systems and requests patient medical data from the EHR, runs through the...

Listen

Episode 20

September 05, 2021 00:48:50
Episode Cover

Startup Profile: Lactiga (020)

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...

Listen